Related Experiment Video
Updated: Dec 12, 2025
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
12.8K
STAT1 expression and HPV16 viral load predict cervical lesion progression.
Si Wu1, Yingying Wu1, Yiping Lu1
1Department of Biobank, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.
Oncology Letters
|August 11, 2020
Summary
Signal transducer and activator of transcription 1 (STAT1) expression increases with cervical lesion severity and human papillomavirus (HPV)16 load. STAT1 and HPV16 together can distinguish cervical cancer, with STAT1 indicating lesion status.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Cervical cancer is a major global health concern, with unclear molecular drivers.
- Identifying novel diagnostic and prognostic biomarkers is crucial for improving patient outcomes.
- The role of Signal transducer and activator of transcription 1 (STAT1) in cervical lesions, particularly in relation to human papillomavirus (HPV) infection, requires further investigation.
Purpose of the Study:
- To investigate the association between STAT1 expression and human papillomavirus type 16 (HPV16) in cervical lesions.
- To evaluate STAT1 as a potential diagnostic and prognostic biomarker for cervical cancer.
- To explore the correlation between STAT1, HPV16 viral load, and cervical lesion severity.
Main Methods:
- Immunohistochemistry was used to detect STAT1 expression in cervical tissues.
- Quantitative PCR was employed to measure HPV16 viral load and STAT1 expression.
- Receiver operating characteristic (ROC) curve analysis was performed to assess diagnostic potential.
- The Cancer Genome Atlas (TCGA) database was utilized for survival analysis.
Main Results:
- STAT1 expression significantly increased with the progression of cervical lesions, from normal tissue to low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), and cervical squamous cell carcinoma.
- HPV16 viral load showed a positive correlation with lesion severity and STAT1 expression.
- Combined analysis of STAT1 expression and HPV16 viral load demonstrated high accuracy in differentiating between LSIL/HSIL and cervical cancer.
- Bioinformatics analysis indicated that higher STAT1 expression was associated with improved survival in cervical cancer patients.
Conclusions:
- STAT1 expression is positively associated with cervical lesion progression and HPV16 viral load.
- The combination of STAT1 and HPV16 serves as a promising biomarker for distinguishing cervical cancer.
- STAT1 may function as a valuable indicator for assessing the status of cervical lesions and predicting patient survival.
More Related Videos
Related Concept Videos
03:18Non-LTR Retrotransposons
12.9K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.9K
02:07Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K